https://www.indianpharmapost.com/lonza-delivers-56-cer-sales-growth-and-30-core-ebitda-margin-144122023-07-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-receives-positive-european-union-chmp-opinion-for-gefapixant-144132023-07-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-receives-positive-eu-chmp-opinion-for-pembrolizumab-plus-trastuzumab-and-chemotherapy-as-first-line-treatment-for-her2-positive-advanced-gastric-or-gastroesophageal-junction-144142023-07-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/boehringer-ingelheim-receives-fda-approval-for-nexgard-plus-144152023-07-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-launches-luforbec-1006-for-adult-asthma-and-copd-treatment-in-germany-144162023-07-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-life-sciences-reports-robust-25-ebitda-growth-in-q1fy24-144172023-07-22T00:00:00+05:30always0.9